<div><div></div><div><span><p><span>Hims &amp; Hers entered into Amendment No. 3 to its Revolving Credit and Guaranty Agreement to facilitate the closing of its acquisition of Eucalyptus. The amendment provides a post-closing grace period for covenant and representation compliance, adds joinder obligations for material foreign subsidiaries, and increases capacity for downstream investments in non-loan party subsidiaries. Other terms, including interest provisions, fees, covenants and events of default, remain largely unchanged.</span></p><p><strong><span>Agreement details:</span></strong></p><ul><li><strong><span>Agreement type</span></strong><span>: Amendment No. 3 to revolving credit and guaranty agreement</span></li><li><strong><span>Counterparty</span></strong><span>: JPMorgan Chase Bank, as administrative agent, and other lenders and issuing banks</span></li><li><strong><span>Signed / Effective</span></strong><span>: May 29 2026 / same</span></li><li><strong><span>Reason</span></strong><span>: Facilitate Eucalyptus acquisition and adjust covenants and subsidiary joinders</span></li></ul><p><span>Original SEC Filing: </span>Hims &amp; Hers Health, Inc. [ HIMS ] - 8-K - Jun. 02, 2026</p><section><b><span class="heading-JaE7wgR2">Disclaimer</span></b><div><span>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</span></div></section></span></div></div>

HIMS

HIMY

HIMZ

<p>Hims & Hers Health amended its revolving credit agreement with JPMorgan to facilitate the acquisition of Eucalyptus. The amendment introduces a post-closing grace period for covenant compliance, adds joinder obligations for material foreign subsidiaries, and increases capacity for downstream investments in non-loan party subsidiaries. Other terms remain largely unchanged.</p>

TradingView

Hims & Hers Health

JPMorgan Chase

Defiance Leveraged Long +Income HIMS ETF

Defiance Daily Target 2X Long HIMS ETF

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Hims & Hers Amends Revolving Credit Agreement With JPMorgan to Support Eucalyptus Deal